Redfund Capital Corp (CSE:LOAN) (FRA:O3X4) (OTC:PNNRF) is launching a line of pharma-grade cannabidiol nutraceuticals headed by Robert Klein.
The Dr. Klein CBD brand includes a pain cream, healing stick, face moisturizer, infused serum and CBD-infused bath bombs.
The company plans to initially target the US chiropractic community, of which Klein is a member, through online consumer marketing before launching globally in the fall.
“We are pleased to support Dr. Klein and the launch of the Dr. Klein CBD brand of pharma-grade CBD topicals and infused bathing products,” CEO Meris Kolt said. “These products will be laboratory tested prior to sales. We look forward to launching the Dr. Klein brand into Europe, South America and into Canada when regulation allows in the fall of 2019.”
Klein has been the chiropractor for Florida Atlantic University for 15 years and serves on the board of the Florida Chiropractic Association. He earned his doctorate from the National College of Chiropractic in Lombard, Illinois.
Redfund Capital provides debt and equity funding to companies in the medical cannabis community. The company will own an equity stake in Dr. Klein CBD.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel